In this regard, profilin1 (Pfn1) played an anti-cancer role in pancreatic cancer by improving the SIRT3 expression, resulting in the destabilization of HIF-1α to inhibit glycolytic (55). Here, SIRT3 is linked to pancreatic neoplasm.